| Year |
Citation |
Score |
| 2024 |
Hsiao-Nakamoto J, Chiu CL, VandeVrede L, Ravi R, Vandenberg B, De Groot J, Tsogtbaatar B, Fang M, Auger P, Gould NS, Marchioni F, Powers CA, Davis SS, Suh JH, Alkabsh J, ... ... Boxer AL, et al. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia. Biorxiv : the Preprint Server For Biology. PMID 38405775 DOI: 10.1101/2024.02.09.579529 |
0.313 |
|
| 2023 |
Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, Strom A, Gordon B, Mundada N, Schindler SE, Tsoy E, Ma Y, Lu R, Fagan AM, Benzinger TLS, ... ... Boxer AL, et al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280. PMID 37942088 DOI: 10.1093/braincomms/fcad280 |
0.324 |
|
| 2022 |
Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. The Lancet. Neurology. 21: 258-272. PMID 35182511 DOI: 10.1016/S1474-4422(21)00341-0 |
0.305 |
|
| 2020 |
VandeVrede L, Boxer AL, Polydoro M. Targeting tau: Clinical trials and novel therapeutic approaches. Neuroscience Letters. 731: 134919. PMID 32380145 DOI: 10.1016/J.Neulet.2020.134919 |
0.302 |
|
| 2020 |
Toller G, Ranasinghe K, Cobigo Y, Staffaroni A, Appleby B, Brushaber D, Coppola G, Dickerson B, Domoto-Reilly K, Fields J, Fong J, Forsberg L, Ghoshal N, Graff-Radford N, Grossman M, ... ... Boxer A, et al. Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials. Neurology. PMID 32371446 DOI: 10.1212/Wnl.0000000000009451 |
0.314 |
|
| 2020 |
Heuer HW, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber DE, Caso C, Coppola G, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, ... ... Boxer AL, et al. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 60-70. PMID 31914226 DOI: 10.1002/Alz.12046 |
0.347 |
|
| 2019 |
Boeve B, Bove J, Brannelly P, Brushaber D, Coppola G, Dever R, Dheel C, Dickerson B, Dickinson S, Faber K, Fields J, Fong J, Foroud T, Forsberg L, Gavrilova R, ... ... Boxer A, et al. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31636026 DOI: 10.1016/J.Jalz.2019.06.4947 |
0.311 |
|
| 2019 |
Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, et al. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathologica. PMID 31616982 DOI: 10.1007/S00401-019-02080-2 |
0.316 |
|
| 2019 |
Miyagawa T, Brushaber D, Syrjanen J, Kremers W, Fields J, Forsberg LK, Heuer HW, Knopman D, Kornak J, Boxer A, Rosen H, Boeve B. Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31477517 DOI: 10.1016/J.Jalz.2019.05.013 |
0.357 |
|
| 2018 |
Finger E, Berry S, Cummings J, Coleman K, Hsiung R, Feldman HH, Boxer A. Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY). Alzheimer's Research & Therapy. 10: 102. PMID 30261917 DOI: 10.1186/S13195-018-0427-2 |
0.313 |
|
| 2017 |
Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A, Karydas A, Kornak J, Sias AC, Rabinovici GD, Gorno-Tempini ML, Boxer AL, De May M, Rankin KP, Sturm VE, et al. Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain : a Journal of Neurology. PMID 29053860 DOI: 10.1093/Brain/Awx254 |
0.305 |
|
| 2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Boxer A, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.341 |
|
| 2017 |
Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, ... ... Boxer A, et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28500752 DOI: 10.1002/Mds.27034 |
0.337 |
|
| 2017 |
Lopez A, Lee SE, Wojta K, Ramos EM, Klein E, Chen J, Boxer AL, Gorno-Tempini ML, Geschwind DH, Schlotawa L, Ogryzko NV, Bigio EH, Rogalski E, Weintraub S, Mesulam MM, et al. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction. Brain : a Journal of Neurology. PMID 28334843 DOI: 10.1093/Brain/Awx005 |
0.335 |
|
| 2016 |
Bertoux M, Sarazin M, Pasquier F, Bottlaender M, de Souza LC, Mioshi E, Hornberger M, Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, You SC, ... ... Boxer A, et al. Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology. 87: 1523. PMID 27698154 DOI: 10.1212/01.Wnl.0000503343.29930.76 |
0.317 |
|
| 2016 |
Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, Jicha GA, Karydas AM, Boxer A, Miller BL. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27601437 DOI: 10.1096/Fj.201600816R |
0.388 |
|
| 2016 |
Boman A, Svensson S, Boxer A, Rojas JC, Seeley WW, Karydas A, Miller B, Kågedal K, Svenningsson P. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid. Journal of Parkinson's Disease. PMID 27061067 DOI: 10.3233/Jpd-150759 |
0.319 |
|
| 2016 |
Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, Christine You S, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, ... ... Boxer A, et al. Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology. PMID 26802093 DOI: 10.1212/Wnl.0000000000002373 |
0.37 |
|
| 2015 |
Feneberg E, Steinacker P, Volk AE, Weishaupt JH, Wollmer MA, Boxer A, Tumani H, Ludolph AC, Otto M. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26659729 DOI: 10.1007/S00702-015-1486-1 |
0.308 |
|
| 2015 |
Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Carlson OD, Mustapic M, Kapogiannis D. Low neural exosomal levels of cellular survival factors in Alzheimer's disease. Annals of Clinical and Translational Neurology. 2: 769-73. PMID 26273689 DOI: 10.1002/Acn3.211 |
0.33 |
|
| 2015 |
Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 85: 40-7. PMID 26062630 DOI: 10.1212/Wnl.0000000000001702 |
0.362 |
|
| 2015 |
Chen JA, Wang Q, Davis-Turak J, Li Y, Karydas AM, Hsu SC, Sears RL, Chatzopoulou D, Huang AY, Wojta KJ, Klein E, Lee J, Beekly DL, Boxer A, Faber KM, et al. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. Jama Neurology. 72: 414-22. PMID 25706306 DOI: 10.1001/Jamaneurol.2014.4040 |
0.39 |
|
| 2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Boxer A, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.372 |
|
| 2015 |
Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, Frassetto L, Petersen RC, Miller BL, Goetzl EJ. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 589-96. PMID 25342129 DOI: 10.1096/Fj.14-262048 |
0.34 |
|
| 2015 |
Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 600-7.e1. PMID 25130657 DOI: 10.1016/J.Jalz.2014.06.008 |
0.367 |
|
| 2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Boxer A, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.324 |
|
| 2014 |
Tartaglia MC, Hu B, Mehta K, Neuhaus J, Yaffe K, Miller BL, Boxer A. Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease. Alzheimer Disease and Associated Disorders. 28: 182-9. PMID 23995817 DOI: 10.1097/Wad.0B013E3182A7159D |
0.351 |
|
| 2014 |
Kapogiannis D, Fiandaca MS, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller B, Goetzl EJ. Pathogenic Proteins In Neurally-Derived Blood Exosomes As Near-Perfect Diagnostic And Prognostic Biomarkers For Alzheimer'S Disease Alzheimers & Dementia. 10: 281. DOI: 10.1016/J.Jalz.2014.07.152 |
0.345 |
|
| 2013 |
Kepe V, Bordelon Y, Boxer A, Huang SC, Liu J, Thiede FC, Mazziotta JC, Mendez MF, Donoghue N, Small GW, Barrio JR. PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. Journal of Alzheimer's Disease : Jad. 36: 145-53. PMID 23579330 DOI: 10.3233/Jad-130032 |
0.324 |
|
| 2013 |
Lee SE, Tartaglia MC, Yener G, Genç S, Seeley WW, Sanchez-Juan P, Moreno F, Mendez MF, Klein E, Rademakers R, López de Munain A, Combarros O, Kramer JH, Kenet RO, Boxer AL, et al. Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Disease and Associated Disorders. 27: 302-9. PMID 23518664 DOI: 10.1097/Wad.0B013E31828Cc357 |
0.331 |
|
| 2012 |
Sha SJ, Boxer A. Treatment implications of C9ORF72. Alzheimer's Research & Therapy. 4: 46. PMID 23186535 DOI: 10.1186/Alzrt149 |
0.359 |
|
| 2012 |
Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, Khan B, Karydas A, Baker MC, DeJesus-Hernandez M, Pribadi M, Coppola G, Geschwind DH, Rademakers R, Lee SE, ... ... Boxer AL, et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology. 79: 1002-11. PMID 22875087 DOI: 10.1212/Wnl.0B013E318268452E |
0.301 |
|
| 2012 |
Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, ... ... Boxer AL, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Human Molecular Genetics. 21: 3500-12. PMID 22556362 DOI: 10.1093/Hmg/Dds161 |
0.401 |
|
| 2012 |
Boxer AL, Garbutt S, Seeley WW, Jafari A, Heuer HW, Mirsky J, Hellmuth J, Trojanowski JQ, Huang E, DeArmond S, Neuhaus J, Miller BL. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease. Archives of Neurology. 69: 509-17. PMID 22491196 DOI: 10.1001/Archneurol.2011.1021 |
0.301 |
|
| 2012 |
Khan B, Rankin K, Sha S, Takada L, Yokoyama J, Karydas A, Fong J, Rutherford N, Baker M, DeJesus-Hernandez M, Coppola G, Rademakers R, Rosen H, Seeley W, Boxer A, et al. C9ORF72 Mutations in Two Patients with Slowly Progressive bvFTD "Phenocopy" (S54.006) Neurology. 78: S54.006-S54.006. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S54.006 |
0.376 |
|
| 2012 |
Finger E, Jesso S, Rankin K, Boxer A, Kertesz A. A Dose Finding Study of Intranasal Oxytocin in Behavioural Variant Frontotemporal Dementia (S29.007) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S29.007 |
0.322 |
|
| 2010 |
Tartaglia MC, Hu B, Mehta K, Miller BL, Boxer A. Medication use differs in frontotemporal dementia and Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.2007 |
0.37 |
|
| 2009 |
Pa J, Boxer A, Chao LL, Gazzaley A, Freeman K, Kramer J, Miller BL, Weiner MW, Neuhaus J, Johnson JK. Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Annals of Neurology. 65: 414-23. PMID 19399879 DOI: 10.1002/Ana.21591 |
0.306 |
|
| 2009 |
Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno-Tempini ML. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proceedings of the National Academy of Sciences of the United States of America. 106: 2018-22. PMID 19164761 DOI: 10.1073/Pnas.0812697106 |
0.311 |
|
| 2009 |
Raskind M, Liang E, Sperling R, Boxer A, Ross J, Brody M, Garzone P, Raje S, Black R, Grundman M. Pharmacokinetics and pharmacodynamics of bapineuzumab following multiple intravenous infusions in patients with mild-to-moderate Alzheimer's disease Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.04.1019 |
0.37 |
|
| 2008 |
Webb A, Miller B, Bonasera S, Boxer A, Karydas A, Wilhelmsen KC. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders. Archives of Neurology. 65: 1473-8. PMID 19001166 DOI: 10.1001/Archneur.65.11.1473 |
0.356 |
|
| 2007 |
Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature Medicine. 13: 1359-62. PMID 17934472 DOI: 10.1038/Nm1653 |
0.386 |
|
| 2005 |
Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VM, Grossman M, Miller BL. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 65: 1817-9. PMID 16344531 DOI: 10.1212/01.Wnl.0000187068.92184.63 |
0.36 |
|
| 2003 |
Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, Rosen HJ. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Archives of Neurology. 60: 949-56. PMID 12873851 DOI: 10.1001/Archneur.60.7.949 |
0.305 |
|
| Show low-probability matches. |